While SNAIL modulation did not alter primary tumor growth, its link to metastasis suggests a stage-specific therapeutic role for a SNAIL-targeting strategy in advanced, high-risk bladder cancer to prevent initial metastasis or progressive disease. This evidence concerns the gene SNAI1 and urinary bladder carcinoma.